CELZ
CELZ
NASDAQ · Biotechnology

Creative Medical Technology

$0.81
-0.39 (-32.48%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,021.2% upside
Low Target $22.85
Average Target $33.39
High Target $43.53
Current Price $0.81
Current
$0.81
Target
$33.39
$22.85 $33.39 avg $43.53
Scenario Analysis
Bear Case
$22.85
2,720.3%
Low target
Base Case
$33.39
+4,021.2%
Avg target
Bull Case
$43.53
+5,272.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.25
-87.0% from high
52-Week Low
$1.50
+-46.1% from low
Target vs 52W High
$33.39
+434.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%